PURPOSE: The purpose of the present study was to explore the participation in physical activity (PA) by colorectal cancer survivors across cancer trajectories and based on selected demographic and medical variables. METHODS: A total of 431 participants were surveyed individually at the Shinchon Severance Hospital, Seoul, Korea, to determine their PA levels before diagnosis, during treatment and after completion of cancer treatment. RESULTS: Percentage of survivors meeting American College of Sports Medicine guideline significantly reduced from 27% before diagnosis to 10% during treatment due to reduced strenuous intensity PA (28.8 ± 106.2 vs. 11.8 ± 95.9 min, p = 0.042), while total PA and mild intensity PA did not change. Total (187.2 ± 257.7 vs. 282.6 ± 282.0 min, p < 0.001) and mild (99.1 ± 191.5 vs. 175.1 ± 231.2 min, p < 0.001) intensity PA significantly increased after the completion of treatments compared with their PA level before diagnosis. Further analyses showed that age (more vs. equal or less than 60 years) and chemotherapy (chemotherapy vs. no chemotherapy) significantly influenced the level of physical activity (p = 0.004). Survivors who were older or received chemotherapy increased their total PA and mild intensity PA after the completion of treatment more than those who did not receive chemotherapy. CONCLUSIONS: The level and the pattern of physical activity by colorectal cancer survivors differed across cancer trajectories, which were significantly influenced by age and adjuvant chemotherapy.
PURPOSE: The purpose of the present study was to explore the participation in physical activity (PA) by colorectal cancer survivors across cancer trajectories and based on selected demographic and medical variables. METHODS: A total of 431 participants were surveyed individually at the Shinchon Severance Hospital, Seoul, Korea, to determine their PA levels before diagnosis, during treatment and after completion of cancer treatment. RESULTS: Percentage of survivors meeting American College of Sports Medicine guideline significantly reduced from 27% before diagnosis to 10% during treatment due to reduced strenuous intensity PA (28.8 ± 106.2 vs. 11.8 ± 95.9 min, p = 0.042), while total PA and mild intensity PA did not change. Total (187.2 ± 257.7 vs. 282.6 ± 282.0 min, p < 0.001) and mild (99.1 ± 191.5 vs. 175.1 ± 231.2 min, p < 0.001) intensity PA significantly increased after the completion of treatments compared with their PA level before diagnosis. Further analyses showed that age (more vs. equal or less than 60 years) and chemotherapy (chemotherapy vs. no chemotherapy) significantly influenced the level of physical activity (p = 0.004). Survivors who were older or received chemotherapy increased their total PA and mild intensity PA after the completion of treatment more than those who did not receive chemotherapy. CONCLUSIONS: The level and the pattern of physical activity by colorectal cancer survivors differed across cancer trajectories, which were significantly influenced by age and adjuvant chemotherapy.
Authors: Erin L McGowan; Amy E Speed-Andrews; Ryan E Rhodes; Chris M Blanchard; S Nicole Culos-Reed; Christine M Friedenreich; Kerry S Courneya Journal: Support Care Cancer Date: 2012-05-26 Impact factor: 3.603
Authors: Kerry S Courneya; Kristina H Karvinen; Kristin L Campbell; Robert G Pearcey; George Dundas; Valerie Capstick; Katia S Tonkin Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charles S Fuchs Journal: J Clin Oncol Date: 2006-07-05 Impact factor: 44.544
Authors: V Mock; K H Dow; C J Meares; P M Grimm; J A Dienemann; M E Haisfield-Wolfe; W Quitasol; S Mitchell; A Chakravarthy; I Gage Journal: Oncol Nurs Forum Date: 1997-07 Impact factor: 2.172
Authors: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna R Hollis; A David McCollum; Denise Brady; Michael J O'Connell; Robert J Mayer; Bernard Cummings; Christopher Willett; John S Macdonald; Al B Benson; Charles S Fuchs Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Ji-Hye Park; Junga Lee; Minsuk Oh; Hyuna Park; Jisuk Chae; Dong-Il Kim; Mi Kyung Lee; Yong Jin Yoon; Chul Won Lee; Seho Park; Lee W Jones; Nam Kyu Kim; Seung Il Kim; Justin Y Jeon Journal: Cancer Date: 2015-05-12 Impact factor: 6.860
Authors: Sally A D Romero; Lee Jones; Joshua M Bauml; Q Susan Li; Roger B Cohen; Jun J Mao Journal: Support Care Cancer Date: 2018-04-19 Impact factor: 3.603
Authors: Ji Young Kim; Samuel Yoo; Su Jin Yeon; Ji Hee Min; Dong-Il Kim; Ji Won Lee; Jung Woo Han; Chuhl Joo Lyu; Justin Y Jeon Journal: Support Care Cancer Date: 2021-10-02 Impact factor: 3.603
Authors: Nicole L Stout; Justin C Brown; Anna L Schwartz; Timothy F Marshall; Anna M Campbell; Larissa Nekhlyudov; David S Zucker; Karen M Basen-Engquist; Grace Campbell; Jeffrey Meyerhardt; Andrea L Cheville; Kelley R Covington; Jennifer A Ligibel; Jonas M Sokolof; Kathryn H Schmitz; Catherine M Alfano Journal: Cancer Date: 2020-03-25 Impact factor: 6.860
Authors: Theresa Coles; Antonia V Bennett; Xianming Tan; Claudio L Battaglini; Hanna K Sanoff; Ethan Basch; Roxanne E Jensen; Bryce B Reeve Journal: Support Care Cancer Date: 2018-02-22 Impact factor: 3.603
Authors: Ji-Hye Park; Minsuk Oh; Yong Jin Yoon; Chul Won Lee; Lee W Jones; Seung Il Kim; Nam Kyu Kim; Justin Y Jeon Journal: BMC Cancer Date: 2015-04-10 Impact factor: 4.430
Authors: Gill Hubbard; Richard Adams; Anna Campbell; Lisa Kidd; Stephen J Leslie; Julie Munro; Angus Watson Journal: BMJ Open Date: 2016-01-04 Impact factor: 2.692